# Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

> **NCT03107416** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Unresectable Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Hepatic artery embolization (HAE)
- **DRUG:** Bumetanide

## Key facts

- **NCT ID:** NCT03107416
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-05
- **Primary completion:** 2027-04-05
- **Final completion:** 2027-04-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03107416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03107416, "Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03107416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*